Author = Wael Edesa
| Number of Articles: 4 | ||
| 1 | Genetic Variants of MicroRNA-146a and MicroRNA-196a2 are Associated with Poor Outcome but not Risk of High-Grade B- Cell Non-Hodgkin Lymphoma | |
| Volume 18, Issue 1, June 2022, Page 37-44 | ||
| Somaia M. Mousa; Hala Shiba; Sahar Kamal; Doaa S. Mahmoud; Wael A. Edesa | ||
| 2 | Factors Influencing the Response Rate and Survival of Testicular Germ Cell Tumors: A Single Institution Experience from Egypt | |
| Volume 17, Issue 2, December 2021, Page 66-72 | ||
| Hussam H. Zawam; Ahmed Selim; Nada O. Osman; Wael Edesa | ||
| 3 | Third line Treatment in Relapsed/Refractory Hodgkin's Lymphoma and Aggressive non-Hodgkin Lymphoma after 2nd line ESHAP or GEMOX | |
| Volume 14, Issue 1, June 2018, Page 17-20 | ||
| Hamdy Zawam; Wael Edesa; Sherif Alrefai; Ahmed Abdelhafeez | ||
| 4 | ESHAP versus GEMOX in Management of Relapsed or Refractory Lymphoma: A Prospective Randomized Study | |
| Volume 14, Issue 1, June 2018, Page 12-16 | ||
| Hamdy Zawam; Wael Edesa; Sherif Alrefai; Rasha Salama; Ahmed Abdelhafeez | ||
View on SCiNiTO